FDA Issues Draft Guidance on MRD Testing

Cancer Discovery - United States
doi 10.1158/2159-8290.cd-nb2018-145
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors

Unknown

Publisher

American Association for Cancer Research (AACR)

Related search

Implications of the FDA Draft Guidance on Biosimilars for Clinicians: What We Know and Don't Know

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2013English

On Statistical Principles for Clinical Trials in Pharmaceutical Development-A Review of China FDA Draft Guidance

Pharmaceutical Regulatory Affairs: Open Access
2015English

fDA Guidance for Industry 1 Dissolution Testing of Immediate Release Solid Oral Dosage Forms

Dissolution Technologies
Pharmaceutical Science
1997English

From the FDA: FDA Issues Final Rule on Drug Products Containing Colloidal Silver

Journal of the American Osteopathic Association, The
MedicineAlternative MedicineComplementary
1999English

FDA Guidance on Cardiovascular Risk of Antidiabetic Therapies: One Decade Later

Diabetes, Obesity and Metabolism
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

Draft Guidance on Clinical Trials Recognises Needs of Non-Commercial Research

BMJ
2004English

Perspectives on the Draft ICH-M10 Guidance: An Interview With Eric J Woolf

Bioanalysis
PharmacologyAnalytical ChemistryMedical Laboratory TechnologyClinical BiochemistryMedicineToxicologyPharmaceutics
2019English

Draft Versus Final Guidance in Nice’s Drug Technology Appraisal Process

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Blinatumomab Approval Expanded Based on MRD

Cancer Discovery
Oncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy